Applications cliniques de la tomographie par cohérence optique (TCO) dans le glaucome
Résumé
Le test du champ visuel (CV) représente le pilier du diagnostic et de la surveillance du glaucome. Toutefois, le risque d’un retard de diagnostic pour le patient aux premiers stades de la maladie ne peut être exclu si l’on se repose uniquement sur le CV, car il est connu que les modifications structurales précèdent les modifications fonctionnelles, et que les anomalies du CV peuvent ne pas être cliniquement décelables avant la perte d’au moins 25 à 35 % des cellules ganglionnaires rétiniennes (CGR). Ce concept souligne l’importance d’autres modalités de diagnostic telles que la tomographie par cohérence optique (TCO). La capacité de la TCO à différencier et à quantifier fiablement l’épaisseur des couches rétiniennes a permis la détection précoce du glaucome, jusqu’à 6 ans avant la survenue de toute perte décelable du CV. Par rapport aux tests du CV, la TCO est moins chronophage et moins dépendante de la coopération du patient et de sa capacité à passer le test. Quelques appareils TCO à domaine spectral (TCO-DS) sont disponibles sur le marché et sont couramment utilisés dans les centres de traitement du glaucome. Ces appareils sont pratiquement identiques et leurs performances sont comparables, mais leurs protocoles de balayage et leurs algorithmes de segmentation diffèrent; par conséquent, les paramètres mesurés ne sont pas nécessairement interchangeables entre les appareils et les valeurs doivent être interprétées par rapport aux bases de données normatives spécifiques à chacun d’eux. Cet article présente les applications cliniques de l’imagerie TCO dans le glaucome et partage quelques perles et pièges cliniques.
Références
Kuang TM, Zhang C, Zangwill LM, Weinreb RN, Medeiros FA. Estimating Lead Time Gained by Optical Coherence Tomography in Detecting Glaucoma before Development of Visual Field Defects. Ophthalmology. 2015 Oct;122(10):2002-9. doi:10.1016/j.ophtha.2015.06.015
Kalyani VK, Bharucha KM, Goyal N, Deshpande MM. Comparison of diagnostic ability of standard automated perimetry, short wavelength automated perimetry, retinal nerve fiber layer thickness analysis and ganglion cell layer thickness analysis in early detection of glaucoma. Indian J Ophthalmol. 2021 May;69(5):1108-1112. doi:10.4103/ijo.IJO_2409_20
Fortune B, Cull GA, Burgoyne CF. Relative course of retinal nerve fiber layer birefringence and thickness and retinal function changes after optic nerve transection. Invest Ophthalmol Vis Sci. 2008 Oct;49(10):4444-52. doi:10.1167/iovs.08-2255
Chua J, Tan B, Ke M, et al. Diagnostic Ability of Individual Macular Layers by Spectral-Domain OCT in Different Stages of Glaucoma. Ophthalmol Glaucoma. 2020 Sep;3(5):314-326. doi:10.1016/j.ogla.2020.04.003
Jammal AA, Thompson AC, Mariottoni EB, et al. Rates of Glaucomatous Structural and Functional Change From a Large Clinical Population: The Duke Glaucoma Registry Study. Am J Ophthalmol. 2021 Feb;222:238-247. doi:10.1016/j.ajo.2020.05.019
Bowd C, Zangwill LM, Weinreb RN, Medeiros FA, Belghith A. Estimating Optical Coherence Tomography Structural Measurement Floors to Improve Detection of Progression in Advanced Glaucoma. Am J Ophthalmol. 2017 Mar;175:37-44. doi:10.1016/j.ajo.2016.11.010
Sung KR, Na JH, Lee Y. Glaucoma diagnostic capabilities of optic nerve head parameters as determined by Cirrus HD optical coherence tomography. J Glaucoma. 2012 Sep;21(7):498-504. doi:10.1097/IJG.0b013e318220dbb7
Shin JW, Sung KR, Lee GC, Durbin MK, Cheng D. Ganglion Cell-Inner Plexiform Layer Change Detected by Optical Coherence Tomography Indicates Progression in Advanced Glaucoma. Ophthalmology. 2017 Oct;124(10):1466-1474. doi:10.1016/j.ophtha.2017.04.023
Gedde SJ, Vinod K, Wright MM, et al. Primary Open-Angle Glaucoma Preferred Practice Pattern(R). Ophthalmology. 2021 Jan;128(1):P71-P150. doi:10.1016/j.ophtha.2020.10.022
European Glaucoma Society Terminology and Guidelines for Glaucoma, 5th Edition. Br J Ophthalmol. 2021 Jun;105(Suppl 1):1-169. doi:10.1136/bjophthalmol-2021-egsguidelines
Mahmoudinezhad G, Moghimi S, Proudfoot JA, et al. Effect of Testing Frequency on the Time to Detect Glaucoma Progression with OCT and OCT Angiography. Am J Ophthalmol. 2022 Sep 9. doi:10.1016/j.ajo.2022.08.030
Melchior B, De Moraes CG, Paula JS, et al. Frequency of Optical Coherence Tomography Testing to Detect Progression in Glaucoma. J Glaucoma. 2022 Aug 11. doi:10.1097/IJG.0000000000002101
Shoji T, Sato H, Ishida M, Takeuchi M, Chihara E. Assessment of glaucomatous changes in subjects with high myopia using spectral domain optical coherence tomography. Invest Ophthalmol Vis Sci. 2011 Feb 25;52(2):1098-102. doi:10.1167/iovs.10-5922
Ganekal S, Sadhwini MH, Kagathur S. Effect of myopia and optic disc area on ganglion cell-inner plexiform layer and retinal nerve fiber layer thickness. Indian J Ophthalmol. 2021 Jul;69(7):1820-1824. doi:10.4103/ijo.IJO_2818_20
Rolle T, Bonetti B, Mazzucco A, Dallorto L. Diagnostic ability of OCT parameters and retinal ganglion cells count in identification of glaucoma in myopic preperimetric eyes. BMC Ophthalmol. 2020 Sep 22;20(1):373. doi:10.1186/s12886-020-01616-5
Seo S, Lee CE, Jeong JH, Park KH, Kim DM, Jeoung JW. Ganglion cell-inner plexiform layer and retinal nerve fiber layer thickness according to myopia and optic disc area: a quantitative and three-dimensional analysis. BMC Ophthalmol. 2017 Mar 11;17(1):22. doi:10.1186/s12886-017-0419-1
Mwanza JC, Durbin MK, Budenz DL, Cirrus OCTNDSG. Interocular symmetry in peripapillary retinal nerve fiber layer thickness measured with the Cirrus HD-OCT in healthy eyes. Am J Ophthalmol. 2011 Mar;151(3):514-21 e1. doi:10.1016/j.ajo.2010.09.015
Dalgliesh JD, Tariq YM, Burlutsky G, Mitchell P. Symmetry of retinal parameters measured by spectral-domain OCT in normal young adults. J Glaucoma. 2015 Jan;24(1):20-4. doi:10.1097/IJG.0b013e318287ac2f
Lee SY, Jeoung JW, Park KH, Kim DM. Macular ganglion cell imaging study: interocular symmetry of ganglion cell-inner plexiform layer thickness in normal healthy eyes. Am J Ophthalmol. 2015 Feb;159(2):315-23 e2. doi:10.1016/j.ajo.2014.10.032
Cheung CY, Yiu CK, Weinreb RN, et al. Effects of scan circle displacement in optical coherence tomography retinal nerve fibre layer thickness measurement: a RNFL modelling study. Eye (Lond). 2009 Jun;23(6):1436-41. doi:10.1038/eye.2008.258
Lee EJ, Lee KM, Kim H, Kim TW. Glaucoma Diagnostic Ability of the New Circumpapillary Retinal Nerve Fiber Layer Thickness Analysis Based on Bruch’s Membrane Opening. Invest Ophthalmol Vis Sci. 2016 Aug 1;57(10):4194-204. doi:10.1167/iovs.16-19578
Hardin JS, Taibbi G, Nelson SC, Chao D, Vizzeri G. Factors Affecting Cirrus-HD OCT Optic Disc Scan Quality: A Review with Case Examples. J Ophthalmol. 2015;2015:746150. doi:10.1155/2015/746150
Tatham AJ, Medeiros FA. Detecting Structural Progression in Glaucoma with Optical Coherence Tomography. Ophthalmology. 2017 Dec;124(12S):S57-S65. doi:10.1016/j.ophtha.2017.07.015
Yang Z, Tatham AJ, Zangwill LM, Weinreb RN, Zhang C, Medeiros FA. Diagnostic ability of retinal nerve fiber layer imaging by swept-source optical coherence tomography in glaucoma. Am J Ophthalmol. 2015 Jan;159(1):193-201. doi:10.1016/j.ajo.2014.10.019
Kim YW, Lee J, Kim JS, Park KH. Diagnostic Accuracy of Wide-Field Map from Swept-Source Optical Coherence Tomography for Primary Open-Angle Glaucoma in Myopic Eyes. Am J Ophthalmol. 2020 Oct;218:182-191. doi:10.1016/j.ajo.2020.05.032
Lee SY, Bae HW, Kwon HJ, Seong GJ, Kim CY. Repeatability and Agreement of Swept Source and Spectral Domain Optical Coherence Tomography Evaluations of Thickness Sectors in Normal Eyes. J Glaucoma. 2017 Feb;26(2):e46-e53. doi:10.1097/IJG.0000000000000536
Moghimi S, Bowd C, Zangwill LM, et al. Measurement Floors and Dynamic Ranges of OCT and OCT Angiography in Glaucoma. Ophthalmology. 2019 Jul;126(7):980-988. doi:10.1016/j.ophtha.2019.03.003
Sehi M, Grewal DS, Sheets CW, Greenfield DS. Diagnostic ability of Fourier-domain vs time-domain optical coherence tomography for glaucoma detection. Am J Ophthalmol. 2009 Oct;148(4):597-605. doi:10.1016/j.ajo.2009.05.030
Mesiwala NK, Pekmezci M, Huang JY, Porco TC, Lin SC. Comparison of optic disc parameters measured by RTVue-100 FDOCT versus HRT-II. J Glaucoma. 2012 Oct;21(8):516-22. doi:10.1097/IJG.0b013e3182253e58
Huang Y, Gangaputra S, Lee KE, et al. Signal quality assessment of retinal optical coherence tomography images. Invest Ophthalmol Vis Sci. 2012 Apr 24;53(4):2133-41. doi:10.1167/iovs.11-8755
Gonzalez-Garcia AO, Vizzeri G, Bowd C, Medeiros FA, Zangwill LM, Weinreb RN. Reproducibility of RTVue retinal nerve fiber layer thickness and optic disc measurements and agreement with Stratus optical coherence tomography measurements. Am J Ophthalmol. 2009 Jun;147(6):1067-74, 1074 e1. doi:10.1016/j.ajo.2008.12.032
Chen TC, Hoguet A, Junk AK, et al. Spectral-Domain OCT: Helping the Clinician Diagnose Glaucoma: A Report by the American Academy of Ophthalmology. Ophthalmology. 2018 Nov;125(11):1817-1827. doi:10.1016/j.ophtha.2018.05.008
Buchser NM, Wollstein G, Ishikawa H, et al. Comparison of retinal nerve fiber layer thickness measurement bias and imprecision across three spectral-domain optical coherence tomography devices. Invest Ophthalmol Vis Sci. 2012 Jun 20;53(7):3742-7. doi:10.1167/iovs.11-8432
Heidelberg Engineering. 510(k) summary: spectralis HRA+OCT and variants. Food Drug Adm. [accessed 2022 oct 5]. https://www.accessdata.fda.gov/cdrh_docs/pdf15/K152205.pdf.
Carl Zeiss Meditec, Inc. 510(k) summary: Cirrus HD-OCT with retinal nerve fiber layer and macular normative databases. Food Drug Adm. [accessed 2022 Oct 5]. https://www.accessdata.fda.gov/cdrh_docs/pdf8/K083291.pdf.
Topcon Corporation. 510(k) summary: 3D OCT-1 Maestro. Food Drug Adm. [accessed 2022 Oct 5]. https://www.accessdata.fda.gov/cdrh_docs/pdf16/K161509.pdf.
Optovue Inc. 510(k) summary: RTVue with Normative Database. Food Drug Adm. [accessed 2022 Oct 5]. https://www.accessdata.fda.gov/cdrh_docs/pdf10/K101505.pdf.
Publié
Comment citer
Numéro
Rubrique
Licence
© Canadian Eye Care Today 2022
Cette œuvre est sous licence Creative Commons Attribution - Pas d'Utilisation Commerciale - Pas de Modification 4.0 International.
